2018 to 2022 Saw Increase in GLP-1 Receptor Agonist Use in Adults Without Diabetes

Pooled annual prevalence of GLP-1 RA use was 0.1 percent from 2018 to 2021 and increased to 0.4 percent by 2022
injector pen ozempic wegovy
Adobe Stock
Medically Reviewed By:
Mark Arredondo, M.D.
Published on
Updated on
Loading content, please wait...

Related Stories

No stories found.
logo
www.healthday.com